Zika Virus Vaccine Programme
A new Zika vaccine based on a simian adenoviral vector is being developed in Oxford to determine if it is immunogenic and can be taken to clinical trials. This development is part of a global rapid response programme.
May 11, 2016
Deixe uma resposta
Want to join the discussion?Feel free to contribute!